Sermorelin ODT

How Sermorelin ODT works

Sermorelin is a 29-amino-acid fragment of growth hormone-releasing hormone (GHRH). It binds GHRH receptors in the pituitary and prompts it to release your own growth hormone in pulses. The body's normal feedback controls, such as somatostatin and IGF-1, still apply, which is different from injecting growth hormone directly.

Who it’s for, and who it isn’t

What’s included

• Clinician review of goals, history and other medicines
• Optional baseline IGF-1 and glucose labs (priced separately)
• Medication shipped from a licensed U.S. pharmacy
• Follow-up to decide whether to continue

Possible side effects

• Flushing
• Headache
• Nausea or mouth irritation
• Dizziness
• Possible rises in blood sugar
• Fluid retention or joint aches if growth hormone activity rises substantially

This isn’t a complete list. Your clinician reviews risks, interactions and warnings with you before prescribing. In an emergency, call 911.

What the evidence says

Injectable sermorelin was FDA-approved (as Geref) to diagnose and treat growth hormone deficiency in children, and studies show it raises growth hormone and IGF-1. Evidence for benefits in healthy middle-aged adults, such as better sleep, body composition or energy, comes from small, short studies. There are no published controlled trials of a sermorelin dissolving tablet, and how much is absorbed through the mouth is not established.

What sermorelin is

Your hypothalamus releases growth hormone-releasing hormone, GHRH, which tells the pituitary gland to release growth hormone. Growth hormone then drives the liver to make IGF-1, which carries out many of its effects on muscle, bone, fat and repair. Both growth hormone and IGF-1 tend to decline with age.

Sermorelin mimics the active part of GHRH. Instead of supplying growth hormone, it encourages your pituitary to make more of its own, within the limits of normal feedback. That is the main reason it is often described as gentler than growth hormone injections, though gentler does not mean proven.

Its regulatory history

Injectable sermorelin was sold in the U.S. under the brand name Geref, approved for children with growth hormone deficiency and for testing pituitary function. The manufacturer discontinued it in 2008, and in 2013 FDA determined that it was not withdrawn for reasons of safety or effectiveness.

Today sermorelin is available only from compounding pharmacies. The ODT prescribed here is compounded by a licensed U.S. pharmacy; it is not FDA-approved, has not been reviewed by FDA for safety, effectiveness or quality and is not equivalent to the former branded injection. Sermorelin does not appear on FDA's list of bulk substances flagged for significant safety concerns, but that is not the same as an approval.

The honest picture on evidence

It is well documented that sermorelin can raise growth hormone and IGF-1 when injected. What is not well documented is whether that translates into meaningful benefits for healthy adults in their 40s, 50s or 60s. The available studies are small, short and often used injections.

The dissolving tablet adds another unknown. Peptides are usually broken down in the mouth and gut, and absorption through the mouth lining is generally low. No controlled trials have measured how much sermorelin an ODT delivers. Your clinician may check IGF-1 to see whether anything is changing, but a normal IGF-1 response is not proof of benefit.

How the tablet is used

Your prescription label gives the exact instructions, and your clinician sets the dose; this page does not provide home dosing. In general, a dissolving tablet is placed in the mouth and left to dissolve rather than swallowed, often in the evening because the body's largest growth hormone pulses happen during early deep sleep.

Because absorption through the mouth is uncertain, consistency matters. Taking it the same way and at the same time each day, away from food and drink as instructed, gives you and your clinician the best chance of telling whether it is doing anything. Keep a simple log of sleep, energy and recovery for the first few weeks; it is more useful at follow-up than memory.

Who should not take it

Because growth hormone and IGF-1 promote cell growth, anyone with active cancer, or a past cancer without specialist input, should avoid sermorelin. It is not for use during pregnancy or breastfeeding. Untreated thyroid or pituitary problems should be addressed first, since they affect the same hormone systems. Growth hormone activity can raise blood sugar, so people with diabetes need careful review.

Fix the foundations first

Growth hormone is released mainly during deep sleep and after intense exercise. Short or broken sleep, untreated sleep apnea, heavy evening drinking and a sedentary routine all blunt it. Addressing those is free, low-risk and often more effective than any peptide. Your clinician may suggest labs for thyroid, testosterone or estrogen status, iron and blood sugar before considering sermorelin.

What your clinician monitors

If you start, your clinician sets a trial period with clear goals. Follow-up asks about sleep, recovery, energy and any side effects such as headache, flushing or swelling. Labs may include IGF-1 and fasting glucose to make sure levels stay in a sensible range. If nothing has changed after a fair trial, stopping is a reasonable outcome.

Sermorelin ODT is from $199 a month, or $349 for two months ($175 a month), with no membership fee. Labs are billed separately and your price is confirmed at the eligibility review.

Go deeper on Sermorelin ODT